Effects of ROFLUMILAST on markers of subclinical atherosclerosis In stable COPD; the ELASTIC-trial
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms ELASTIC
- 28 Jul 2020 Primary endpoint (Change from baseline in carotid femoral-Pulse Wave Velocity at month 6) has not been met.
- 28 Jul 2020 Results published in the Respirology.
- 24 May 2016 Status changed from active, no longer recruiting to completed.